ArticleInternal medicine (Tokyo, Japan)2026
Extraparenchymal Brain Lesions in Anti-NMDAR Encephalitis Leading to Primary Leptomeningeal Lymphoma: A Rare Evolution with Diagnostic Implications.
Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-N-methyl-d-aspartate receptor encephalitis is an autoimmune disorder typically associated with normal or intraparenchymal brain magnetic resonance imaging (MRI) findings. We herein report a patient who initially presented with extraparenchymal brain lesions and later developed primary leptomeningeal lymphoma (PLML), an uncommon sequence that may inform clinical vigilance and diagnostic refinement. A 49-year-old woman presented with a headache and dysarthria. MRI revealed hyperintensity along the right central sulcus and fluid accumulation in the right frontal epidural space. Anti-NMDAR antibodies were detected in the cerebrospinal fluid, confirming the diagnosis of anti-NMDAR encephalitis. She was treated with steroids, intravenous immunoglobulin, plasma exchange, and cyclophosphamide, which resulted in a full recovery. Two years later, she presented with cerebellar symptoms and was diagnosed with PLML via a brain biopsy. Atypical extraparenchymal brain lesions were present at disease onset. Despite successful initial treatment, the patient later developed PLML, suggesting a potential paraneoplastic relationship or immunological continuum between the two diseases. his case illustrates the diagnostic challenges posed by atypical neuroimaging findings in anti-NMDAR encephalitis and the need for a longitudinal follow-up. Clinicians should consider neoplastic etiologies when imaging or the clinical course deviates from the norm, even if anti-NMDAR antibodies are positive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.